Preliminary results from HERKULES-1: a phase 1b/2, open-label, multicenter study of ERAS-007, an oral ERK1/2 inhibitor, in patients with advanced or metastatic solid tumors

Autor:	J. Wang, M. Johnson, M. Barve, M. Pelster, X. Chen, Z. Li, J. Gordon, M. Reiss, S. Pai, G. Falchook, A. Tolcher
Rok vydání:	2022
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 174:S80-S81
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::180fb81cbbe5321d7e67bb3b4029fe02 https://doi.org/10.1016/s0959-8049(22)01013-9 Zobrazit plný text záznamu Full Text from ScienceDirect